SYVN1 Modulates Papillary Thyroid Carcinoma Progression by Destabilizing HMGB1

Overview

Journal Cell Div

Publisher Biomed Central

Date 2024 Apr 28

PMID 38679705

Authors

Fei Duan

Fanli Kong

Taifeng Jiang

Hongbing Liu

Affiliations

Soon will be listed here.

Abstract

E3 ubiquitin ligase synoviolin (SYVN1) has been reported to participate in many human cancers. This study aimed to investigate SYVN1's roles and molecular pathways in papillary thyroid cancer (PTC). The functions of SYVN1 in PTC were further analyzed using gain- and loss-of-function methods and numerous investigations in cellular function and molecular biology. The findings demonstrated that the overexpression of SYVN1 markedly suppressed the proliferation, migration, and invasion of PTC cell lines (NPA87 and TPC-1). We found that SYVN1 interacted with HMGB1 and promoted its ubiquitination and degradation. In addition, SYVN1 effectively impairs cell proliferation, migration, invasion, and the formation of tumor xenografts in mice models. However, this effect may be partly reversed by overexpressing HMGB1. Thus, SYVN1 may inhibit the proliferation, migration, and invasion of PTC cells by disrupting HMGB1. Consequently, SYVN1 might be considered a promising therapeutic target for PTC.

References

Yao W, Wang J, Zhu L, Jia X, Xu L, Tian X . Epigenetic Regulator KDM4D Restricts Tumorigenesis Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma. Front Oncol. 2021; 11:761346. PMC: 8606580. DOI: 10.3389/fonc.2021.761346. View

Huang D, Zeng Y, Deng H, Fu B, Ke Y, Luo J . SYTL5 Promotes Papillary Thyroid Carcinoma Progression by Enhancing Activation of the NF-κB Signaling Pathway. Endocrinology. 2022; 164(1). DOI: 10.1210/endocr/bqac187. View

Bergdorf K, Ferguson D, Mehrad M, Ely K, Stricker T, Weiss V . Papillary thyroid carcinoma behavior: clues in the tumor microenvironment. Endocr Relat Cancer. 2019; 26(6):601-614. PMC: 8279427. DOI: 10.1530/ERC-19-0074. View

Lam A . Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification. Methods Mol Biol. 2022; 2534:1-15. DOI: 10.1007/978-1-0716-2505-7_1. View

Tan X, He X, Fan Z . Upregulation of HRD1 promotes cell migration and invasion in colon cancer. Mol Cell Biochem. 2018; 454(1-2):1-9. DOI: 10.1007/s11010-018-3447-0. View

Erzurumlu Y, Ballar P . Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer. Sci Rep. 2017; 7:40719. PMC: 5238502. DOI: 10.1038/srep40719. View

Shin J, Kim Y, Lee B, Chang J, Choi H, Lee H . USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity. Mol Med. 2022; 28(1):164. PMC: 9801610. DOI: 10.1186/s10020-022-00596-0. View

Xie Z, Li X, Lun Y, He Y, Wu S, Wang S . Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis. Int Immunopharmacol. 2020; 89(Pt B):107090. DOI: 10.1016/j.intimp.2020.107090. View

Liu L, Long H, Wu Y, Li H, Dong L, Zhong J . HRD1-mediated PTEN degradation promotes cell proliferation and hepatocellular carcinoma progression. Cell Signal. 2018; 50:90-99. DOI: 10.1016/j.cellsig.2018.06.011. View

10.

Fan Y, Wang J, Jin W, Sun Y, Xu Y, Wang Y . CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer. Mol Cancer. 2021; 20(1):25. PMC: 7851937. DOI: 10.1186/s12943-021-01321-x. View

11.

Zeng C, Guo J, Wu J, Che T, Huang X, Liu H . HRD1 promotes non-small cell lung carcinoma metastasis by blocking autophagy-mediated MIEN1 degradation. J Biol Chem. 2023; 299(6):104723. PMC: 10206817. DOI: 10.1016/j.jbc.2023.104723. View

12.

Bhattacharya A, Wei J, Song W, Gao B, Tian C, Wu S . SEL1L-HRD1 ER-associated degradation suppresses hepatocyte hyperproliferation and liver cancer. iScience. 2022; 25(10):105183. PMC: 9550610. DOI: 10.1016/j.isci.2022.105183. View

13.

Liu L, Yu L, Zeng C, Long H, Duan G, Yin G . E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation. Mol Cell Biol. 2020; 40(7). PMC: 7076256. DOI: 10.1128/MCB.00257-19. View

14.

Guo X, Wang A, Wang W, Wang Y, Chen H, Liu X . HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple-negative breast cancer. Mol Oncol. 2020; 15(2):642-656. PMC: 7858277. DOI: 10.1002/1878-0261.12856. View

15.

Zhao Y, Feng Z, Zou Y, Liu Y . The E3 Ubiquitin Ligase SYVN1 Ubiquitinates Atlastins to Remodel the Endoplasmic Reticulum Network. iScience. 2020; 23(9):101494. PMC: 7490852. DOI: 10.1016/j.isci.2020.101494. View

16.

Yamasaki S, Yagishita N, Nishioka K, Nakajima T . The roles of synoviolin in crosstalk between endoplasmic reticulum stress-induced apoptosis and p53 pathway. Cell Cycle. 2007; 6(11):1319-23. DOI: 10.4161/cc.6.11.4277. View